Literature DB >> 25700600

Inhibition of antifungal therapy by gastric acid suppressants.

Harry W Daniell1.   

Abstract

Mesh：

Year:  2015        PMID： 25700600     DOI： 10.1007/s00134-015-3673-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

1.  Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

Authors:  R A Blum; D T D'Andrea; B M Florentino; J H Wilton; D M Hilligoss; M J Gardner; E B Henry; H Goldstein; J J Schentag
Journal:  Ann Intern Med       Date:  1991-05-01       Impact factor: 25.391

2.  The definition of starting point for evaluation of timely adequate antifungal therapy.

Authors:  B Viaggi; C Tascini; F Menichetti
Journal:  Intensive Care Med       Date:  2014-09-23       Impact factor: 17.440

3.  Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole.

Authors:  T W Chin; M Loeb; I W Fong
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

4.  Effect of food and gastric acidity on absorption of orally administered ketoconazole.

Authors:  P Lelawongs; J A Barone; J L Colaizzi; A T Hsuan; W Mechlinski; R Legendre; J Guarnieri
Journal:  Clin Pharm       Date:  1988-03

5.  Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations.

Authors:  Jeroen Walravens; Joachim Brouwers; Isabel Spriet; Jan Tack; Pieter Annaert; Patrick Augustijns
Journal:  Clin Pharmacokinet       Date:  2011-11-01       Impact factor: 6.447

6.  Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.

Authors:  Gopal Krishna; Allen Moton; Lei Ma; Matthew M Medlock; James McLeod
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  Effect of omeprazole on the pharmacokinetics of itraconazole.

Authors:  S Jaruratanasirikul; S Sriwiriyajan
Journal:  Eur J Clin Pharmacol       Date:  1998-04       Impact factor: 2.953

8.  A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.

Authors:  Matteo Bassetti; Elda Righi; Filippo Ansaldi; Maria Merelli; Cecilia Trucchi; Trucchi Cecilia; Gennaro De Pascale; Ana Diaz-Martin; Roberto Luzzati; Chiara Rosin; Leonel Lagunes; Enrico Maria Trecarichi; Maurizio Sanguinetti; Brunella Posteraro; Jose Garnacho-Montero; Assunta Sartor; Jordi Rello; Giorgio Della Rocca; Massimo Antonelli; Mario Tumbarello
Journal:  Intensive Care Med       Date:  2014-05-08       Impact factor: 17.440

9.  Factors influencing posaconazole plasmatic concentrations in patients presenting with acute myeloid leukemia.

Authors:  P-Y Desplanques; R Burlacu; V Poinsignon; H Boussion; I Borget; B Wyplosz; S de Botton; E Billaud; E Chachaty; B Gachot; F Netzer; J-B Micol
Journal:  Med Mal Infect       Date:  2014-03-19       Impact factor: 2.152

10.  Effects of ranitidine and sucralfate on ketoconazole bioavailability.

Authors:  S C Piscitelli; T F Goss; J H Wilton; D T D'Andrea; H Goldstein; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191
View more
  2 in total

1.  Acid-suppressant therapy does not influence absorption of azoles used in candidemia.

Authors:  Bruno Viaggi; Carlo Tascini; Francesco Menichetti
Journal:  Intensive Care Med       Date:  2015-02-21       Impact factor: 17.440

2.  Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability.

Authors:  Daniela Stelzer; Alexandra Weber; Franziska Ihle; Sandhya Matthes; Felix Ceelen; Gregor Zimmermann; Nikolaus Kneidinger; Rene Schramm; Hauke Winter; Michael Zoller; Michael Vogeser; Juergen Behr; Claus Neurohr
Journal:  Ther Drug Monit       Date:  2017-04       Impact factor: 3.681
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.